TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/1/22 16:11 | 5/27/22 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Siber George | NY | D | S | -1 | 0.0653 | 0 | -20 | -99 | 0 | D | |||||||||||||||
9/24/18 20:13 | 8/29/18 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Siber George | NY | D | P.m | 100 | 0.6131 | 0 | 163 | 999% | 165 | D | ||||||||||||||||
5/22/17 16:47 | 5/18/17 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Siber George | NY | D | M.dm | 125 | 2.35 | 0 | 53 | 2 | D | |||||||||||||||||
5/22/17 16:47 | 5/18/17 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Siber George | NY | D | P.dm | 322 | 6.04 | 0 | 53 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |